The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAccrol Gp Regulatory News (ACRL)

Share Price Information for Accrol Gp (ACRL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 38.90
Bid: 38.80
Ask: 38.90
Change: 0.05 (0.13%)
Spread: 0.10 (0.258%)
Open: 38.90
High: 39.90
Low: 38.90
Prev. Close: 38.85
ACRL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Launch of ESG Report

28 Sep 2021 09:46

RNS Number : 2134N
Accrol Group Holdings PLC
28 September 2021
 

 

Reach

 

Accrol Group Holdings plc

("Accrol" or the "Group")

 

Launch of Environmental, Social and Governance Report

 

Accrol, the UK's leading independent tissue converter, is pleased to announce that it has today published its first Environmental, Social and Governance ("ESG") Report, which is available on the Group's website: https://www.accrol.co.uk/esg/  

 

The report sets out the Group's vision for ESG and how it intends to achieve its goals, using clear targets and KPIs and a reporting framework against which progress will be demonstrated.

 

Gareth Jenkins, Chief Executive Officer of Accrol, said:

 

"Accrol's vision is to be a carbon neutral business that improves the lives of its people and communities, while working in partnership with suppliers to deliver sustainable products to customers and consumers and consistent results to our investors.

 

In this, our first sustainability report, we have detailed the actions we are currently taking and how we expect these to benefit both our business and our stakeholders. It also outlines what we plan to do next. Our relentless approach to operational excellence in the business applies equally to ESG and we will use this framework to measure our progress and showcase our performance over time."

 

For further information, please contact:

 

 

 

Accrol Group Holdings plc

 

Dan Wright, Executive Chairman

Via Belvedere Communications

Gareth Jenkins, Chief Executive Officer

Richard Newman, Chief Financial Officer

 

 

 

Zeus Capital Limited (Nominated Adviser & Broker) 

 

Dan Bate / Jordan Warburton

Tel: +44 (0) 161 831 1512

Dominic King / John Goold

Tel: +44 (0) 203 829 5000

 

 

Liberum Capital Limited (Joint Broker)

Tel: +44 (0) 20 3100 2222

Clayton Bush / Edward Thomas

 

 

 

Belvedere Communications Limited

 

Cat Valentine

Tel: +44 (0) 7715 769 078

Keeley Clarke

Tel: +44 (0) 7967 816 525

 

accrolpr@belvederepr.com

 

Overview of Accrol

 

Accrol Group Holdings plc is a leading tissue converter and supplier of toilet tissues, kitchen rolls, facial tissues, and wet wipes to many of the UK's leading discounters and grocery retailers across the UK. Following the recent acquisitions of LTC in Leicester and JD in Flint, North Wales, the Group now operates from six manufacturing sites, including four in Lancashire, which generate revenues totalling c.16% of the £2.1bn UK retail tissue market.

 

For more information, please visit www.accrol.co.uk

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAPPUPCBUPGURR
Date   Source Headline
28th Nov 20221:36 pmRNSLaunch of second ESG Report
21st Nov 20227:00 amRNSHalf Year Trading Update
18th Nov 20227:00 amRNSAwards under LTIP and PDMR dealing
18th Oct 20221:27 pmRNSResult of 2022 Annual General Meeting
23rd Sep 20227:38 amRNSNotice of AGM and Posting of Annual Report 2022
20th Sep 20224:41 pmRNSSecond Price Monitoring Extn
20th Sep 20224:36 pmRNSPrice Monitoring Extension
6th Sep 20227:00 amRNSAudited Final Results
10th Aug 20227:00 amRNSNotice of Final Results and Online Presentations
31st May 202212:21 pmRNSTR-1
17th May 20227:00 amRNSTrading Update - FY22 in line with expectations
10th May 202211:57 amRNSTR-1
7th Apr 20227:00 amRNSTR-1
15th Mar 20223:58 pmRNSTR-1
14th Mar 20227:00 amRNSUpdate on LTC Share Purchase Agreement
11th Mar 20224:41 pmRNSSecond Price Monitoring Extn
11th Mar 20224:36 pmRNSPrice Monitoring Extension
4th Mar 20227:00 amRNSDirector Dealing
24th Feb 20223:45 pmRNSTR-1
24th Feb 20227:00 amRNSAwards under LTIP and PDMR dealing
11th Feb 202212:40 pmRNSTR-1
3rd Feb 20221:59 pmRNSTR-1
2nd Feb 202211:08 amRNSTR-1
21st Jan 20222:42 pmRNSTR-1
18th Jan 20227:00 amRNSHalf Year Results
17th Jan 20226:18 pmRNSTR-1
17th Jan 20223:13 pmRNSTR-1
12th Jan 20227:00 amRNSTrading Update
16th Dec 20217:00 amRNSNotice of Results and Online Investor Presentation
20th Oct 20217:00 amRNSTrading Update
28th Sep 20219:46 amRNSLaunch of ESG Report
24th Sep 202111:59 amRNSResult of AGM
27th Aug 20211:32 pmRNSNotice of AGM and Posting of Annual Report 2021
28th Jul 20215:30 pmRNSTR-1
23rd Jul 20212:35 pmRNSDirector Share Purchase
23rd Jul 20212:31 pmRNSExercise of Options, Director Dealings and TVR
16th Jul 20214:37 pmRNSDirector Shareholding
14th Jul 20217:00 amRNSAudited Final Results
7th Jul 20217:00 amRNSNotice of Results and Online Investor Presentation
4th Jun 202110:38 amRNSTR-1
18th May 20214:41 pmRNSSecond Price Monitoring Extn
18th May 20214:36 pmRNSPrice Monitoring Extension
18th May 20212:06 pmRNSSecond Price Monitoring Extn
18th May 20212:00 pmRNSPrice Monitoring Extension
18th May 202111:05 amRNSSecond Price Monitoring Extn
18th May 202111:00 amRNSPrice Monitoring Extension
18th May 20219:06 amRNSSecond Price Monitoring Extn
18th May 20219:00 amRNSPrice Monitoring Extension
18th May 20217:00 amRNSTrading Update
9th Apr 20217:00 amRNSAcquisition of highly scalable wet wipes business

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.